These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2746918)

  • 1. [Serum lipoprotein analysis of a patient with Tangier disease].
    Takizawa A; Komoda T; Sakagishi Y; Okano K; Doi Y; Tanaka A; Oguro T
    Rinsho Byori; 1989 Mar; 37(3):285-90. PubMed ID: 2746918
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma lipoprotein metabolism in patients with high density lipoprotein deficiency].
    Nakagawa H; Ohtaki S
    Rinsho Byori; 1984 Jul; 32(7):756-63. PubMed ID: 6502976
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of reversed-phase high-performance liquid chromatography to analyse the cholesterol ester profiles present in lipoproteins of patients exhibiting hyperalphalipoproteinaemia or hypoalphalipoproteinaemia (Tangier disease).
    Poll D; Harding DR; Hancock WS; Nye ER; Janus ED; Hannan SF; Scott PJ
    J Chromatogr; 1985 Sep; 343(1):149-54. PubMed ID: 3934204
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of lipoproteins and apolipoproteins in serum of a Tangier patient by micro-scale two-dimensional electrophoresis.
    Manabe T; Visvikis S; Dumon MF; Clerc M; Siest G
    Clin Chem; 1987 Apr; 33(4):468-72. PubMed ID: 3103952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the particle size distribution of plasma lipoprotein in a patient with Tangier disease by high performance liquid chromatography.
    Takizawa A; Komoda T; Hokari S; Sakagishi Y; Tanaka A; Hara I
    Clin Chim Acta; 1990 Dec; 193(1-2):85-7. PubMed ID: 2073749
    [No Abstract]   [Full Text] [Related]  

  • 6. Tangier disease: one explanation of lipid storage.
    Herbert PN; Forte T; Heinen RJ; Fredrickson DS
    N Engl J Med; 1978 Sep; 299(10):519-21. PubMed ID: 210378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal apoprotein A-I isoprotein composition in patients with Tangier disease.
    Zannis VI; Lees AM; Lees RS; Breslow JL
    J Biol Chem; 1982 May; 257(9):4978-86. PubMed ID: 7068673
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunochemical study of the plasma low and high density lipoproteins in Tangier disease.
    Dumon MF; Visvikis S; Manabe T; Clerc M
    FEBS Lett; 1986 May; 201(1):163-7. PubMed ID: 3086124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charge-shift electrophoresis of apolipoproteins from normal humans and patients with Tangier disease.
    Utermann G; Beisiegel U
    FEBS Lett; 1979 Jan; 97(2):245-8. PubMed ID: 216585
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial hypoalphalipoproteinemia: definition of two groups based on plasma triglyceride levels.
    Edelstein C; Fredenrich CL; Scanu AM
    Trans Assoc Am Physicians; 1989; 102():148-57. PubMed ID: 2638523
    [No Abstract]   [Full Text] [Related]  

  • 11. Tangier disease with normal serum cholesterol.
    Frith RW; Hannan SF; Simcock JP; Scott PJ
    Aust N Z J Med; 1982 Oct; 12(5):515-9. PubMed ID: 6960872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density lipoprotein infusion and partial plasma exchange in Tangier disease.
    Assmann G; Smootz E
    Eur J Clin Invest; 1978 Jun; 8(3):131-5. PubMed ID: 211037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Abnormal lipid metabolism in Tangier disease].
    Yamada N; Murase T
    Nihon Rinsho; 1983 Aug; 41(8):1817-23. PubMed ID: 6632290
    [No Abstract]   [Full Text] [Related]  

  • 14. Modified lipid-protein interactions in Tangier beta lipoprotein (LDL2) demonstrated by fluorescence quenching.
    Dumon MF; Dang QQ; Salvayre R; Clerc M; Douste-Blazy L
    Chem Phys Lipids; 1988 Dec; 49(3):153-60. PubMed ID: 3240561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A-I: deficiency in Tangier disease.
    Dumon MF; Clerc M; Clerc M
    Adv Exp Med Biol; 1988; 243():67-73. PubMed ID: 3146917
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of high density lipoprotein with adipocytes in a new patient with Tangier disease.
    Frohlich J; Fong B; Julien P; Despres JP; Angel A; Hayden M; McLeod R; Chow C; Davison RH; Pritchard H
    Clin Invest Med; 1987 Sep; 10(5):377-82. PubMed ID: 3677505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alphalipoproteinemia: evaluation of the utility of its determination].
    Quintão EC
    Arq Bras Cardiol; 1980 Apr; 34(4):263-5. PubMed ID: 7436783
    [No Abstract]   [Full Text] [Related]  

  • 18. Tangier disease apolipoprotein A-I compared with normal plasma A-I using monoclonal antibodies.
    Weech PK; Frohlich J; Marcel YL; N'Guyen TD; Milne RW
    Biochim Biophys Acta; 1985 Jul; 835(2):402-7. PubMed ID: 2408675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction enzyme analysis of the apolipoprotein A-I gene in fish eye disease and Tangier disease.
    Rees A; Stocks J; Schoulders C; Carlson LA; Baralle FE; Galton DJ
    Acta Med Scand; 1984; 215(3):235-7. PubMed ID: 6428166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease.
    Henderson LO; Herbert PN; Fredrickson DS; Heinen RJ; Easterling JC
    Metabolism; 1978 Feb; 27(2):165-74. PubMed ID: 622047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.